|
Immunotherapy
Citations 391-400 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env
- Ke-Qin Xin, Yuka Hoshino, Yoshihiko Toda, Shizunobu Igimi, Yoshitsugu Kojima, Nao Jounai, Kenji Ohba, Akira Kushiro, Mayumi Kiwaki, Kenji Hamajima, Dennis Klinman, and Kenji Okuda
Blood 2003; 102: 223-228.
[Abstract]
[Full text]
[PDF]
Tolerance induction to a mammalian blood group—like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells
- Muhammad M. Mohiuddin, Haruko Ogawa, Deng-Ping Yin, and Uri Galili
Blood 2003; 102: 229-236.
[Abstract]
[Full text]
[PDF]
Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507
- Zhuo Zhang, Meili Zhang, Jeffrey V. Ravetch, Carolyn Goldman, and Thomas A. Waldmann
Blood 2003; 102: 284-288.
[Abstract]
[Full text]
[PDF]
Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans
- Edward James, Jian-Guo Chai, Hamlata Dewchand, Eugenio Macchiarulo, Francesco Dazzi, and Elizabeth Simpson
Blood 2003; 102: 388-393.
[Abstract]
[Full text]
[PDF]
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications
- Emma C. Morris, Peppy Rebello, Kirsty J. Thomson, Karl S. Peggs, Charalampia Kyriakou, Anthony H. Goldstone, Stephen Mackinnon, and Geoff Hale
Blood 2003; 102: 404-406.
[Abstract]
[Full text]
[PDF]
Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity
- Peisheng Hu, Myra Mizokami, Gina Ruoff, Leslie A. Khawli, and Alan L. Epstein
Blood 2003; 101: 4853-4861.
[Abstract]
[Full text]
[PDF]
Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells
- Karsten Mahnke, Yingjie Qian, Jürgen Knop, and Alexander H. Enk
Blood 2003; 101: 4862-4869.
[Abstract]
[Full text]
[PDF]
Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy
- Karina Yazdanbakhsh, Stanley Kang, Daniel Tamasauskas, Dorothy Sung, and Andromachi Scaradavou
Blood 2003; 101: 5046-5052.
[Abstract]
[Full text]
[PDF]
Selective T-cell ablation with bismuth-213–labeled anti-TCR  as nonmyeloablative conditioning for allogeneic canine marrow transplantation
- Wolfgang A. Bethge, D. Scott Wilbur, Rainer Storb, Donald K. Hamlin, Erlinda B. Santos, Martin W. Brechbiel, Darrell R. Fisher, and Brenda M. Sandmaier
Blood 2003; 101: 5068-5075.
[Abstract]
[Full text]
[PDF]
IL-10 and TGF- induce alloreactive CD4+CD25– T cells to acquire regulatory cell function
- Zong-ming Chen, Matthew J. O'Shaughnessy, Irene Gramaglia, Angela Panoskaltsis-Mortari, William J. Murphy, Satwant Narula, Maria G. Roncarolo, and Bruce R. Blazar
Blood 2003; 101: 5076-5083.
[Abstract]
[Full text]
[PDF]
|
|
